Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations
Summary We screened 47 subjects with DDX41 variants among 1529 subjects with myeloid neoplasms. The most common germline variants included Splice c.935 + 4A>T, p.T360Ifs*33, p.V152G, p.S217Ifs*4, p.R311* and p.R369*. Except for the p.R369*, no other variants have been previously reported. Clinica...
Saved in:
Published in | British journal of haematology Vol. 192; no. 6; pp. 1006 - 1010 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Summary
We screened 47 subjects with DDX41 variants among 1529 subjects with myeloid neoplasms. The most common germline variants included Splice c.935 + 4A>T, p.T360Ifs*33, p.V152G, p.S217Ifs*4, p.R311* and p.R369*. Except for the p.R369*, no other variants have been previously reported. Clinical covariates of subjects with simple DDX41 somatic variants and germline/somatic biallelic variants are similar. The two‐year overall survival (OS) of subjects with DDX41 variants was 85%. Overall response rate to demethylation therapy in subjects with DDX41 variants was 69%. The response did not correlate with the presence of a germline variant. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Z.J.X. designed the research, was the principal investigator, and took primary responsibility for the paper; S.Q.Q., B.L. and Z.J.X. acquired the data, analysed and interpreted the data, performed statistical analysis and drafted the article; S.Q.Q., T.J.Q., Z.F.X, B.L., L.J.P., N.B.H., and Z.J.X. recruited the patients; Z.J.X., G.H. and R.P.G. prepared the manuscript. Author contributions |
ISSN: | 0007-1048 1365-2141 |
DOI: | 10.1111/bjh.16668 |